Quantum Biopharma (QNTM) Amortizatization of Intangibles (2024 - 2026)

Quantum Biopharma has reported Amortizatization of Intangibles for 3 years, with the latest figure at $13267.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 95.96% year-over-year to $13267.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $473831.0 (up 45.56% YoY) and the FY2024 annual result came in at $14560.0, changed N/A from the prior year.
• Amortizatization of Intangibles retreated to $13267.0 in Q1 2026 per QNTM's latest filing, from $13505.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $328448.0 in Q1 2025 and troughed at -$17476.0 in Q2 2024.
• A 3-year average of $69770.1 and a median of $14560.0 in 2024 frame the typical range for Amortizatization of Intangibles.
• The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 1779.42% in 2025, then sank 95.96% in 2026.
• Over 3 years, Amortizatization of Intangibles stood at $14560.0 in 2024, then retreated by 7.25% to $13505.0 in 2025, then fell by 1.76% to $13267.0 in 2026.
• According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $13267.0, $13505.0, and $118611.0 for Q1 2026, Q3 2025, and Q2 2025 respectively.